INT11703

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.39
First Reported 1992
Last Reported 2009
Negated 3
Speculated 1
Reported most in Abstract
Documents 7
Total Number 7
Disease Relevance 3.23
Pain Relevance 4.91

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Es2)
Anatomy Link Frequency
jaw 1
temporalis 1
Es2 (Mus musculus)
Pain Link Frequency Relevance Heat
Sumatriptan 5 99.36 Very High Very High Very High
antagonist 1 98.52 Very High Very High Very High
aspirin 12 98.32 Very High Very High Very High
headache 39 98.24 Very High Very High Very High
narcan 1 98.20 Very High Very High Very High
ergotamine 2 98.04 Very High Very High Very High
Migraine 21 97.88 Very High Very High Very High
Analgesic 4 97.60 Very High Very High Very High
Antinociceptive 3 96.36 Very High Very High Very High
Pain 5 96.08 Very High Very High Very High
Disease Link Frequency Relevance Heat
Headache 48 98.24 Very High Very High Very High
Headache Disorders 2 96.72 Very High Very High Very High
Migraine Without Aura 3 95.00 High High
Pain 1 50.00 Quite Low
Nociception 1 5.00 Very Low Very Low Very Low
Urological Neuroanatomy 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We examined the impact of experimentally induced psychophysiological conditions on the latency and duration of the ES2.
Spec (examined) Regulation (impact) of ES2
1) Confidence 0.39 Published 2009 Journal J Psychosom Res Section Abstract Doc Link 19446711 Disease Relevance 0 Pain Relevance 0.14
Sensitivity of ES2 at 0.1 Hz was 67% in episodic tension-type headache, but its positive predictive value versus migraine was excellent.
Regulation (Sensitivity) of ES2 associated with migraine and headache
2) Confidence 0.23 Published 1995 Journal Headache Section Abstract Doc Link 7737867 Disease Relevance 1.06 Pain Relevance 1.28
In chronic tension-type, the sensitivity of the ES2 test was 84% at the 0.1 and the 0.5 Hz, but only 56% at the 2Hz stimulation rates.
Regulation (sensitivity) of ES2
3) Confidence 0.23 Published 1995 Journal Headache Section Abstract Doc Link 7737867 Disease Relevance 0.90 Pain Relevance 1.12
Treatment did not affect the latencies of ES1 and ES2.
Neg (not) Regulation (affect) of ES2
4) Confidence 0.23 Published 1994 Journal Cephalalgia Section Abstract Doc Link 8062353 Disease Relevance 0.84 Pain Relevance 1.25
Various pharmacological agents are able to modify temporalis ES2: its duration is increased by 5-HT1 antagonists, but decreased by 5-HT uptake blockers; contradictory results have been obtained with acetylsalicylic acid.
Regulation (modify) of ES2 in temporalis associated with aspirin and antagonist
5) Confidence 0.23 Published 1993 Journal Cephalalgia Section Abstract Doc Link 8448785 Disease Relevance 0.06 Pain Relevance 0.31
While aspirin caused a highly significant increase in ES2 duration (P less than or equal to 0.001) the taking of placebo showed no significant effect on ES2 duration.
Neg (no) Regulation (effect) of ES2 associated with aspirin
6) Confidence 0.19 Published 1992 Journal Pain Section Abstract Doc Link 1589237 Disease Relevance 0.38 Pain Relevance 0.81
There was no significant modulation of the jaw-stretch reflex (ANOVAs: P=0.929), the ES1 (P=0.298) or ES2 (P=0.082) in any of the three painful conditions.
Neg (no) Regulation (modulation) of ES2 in jaw
7) Confidence 0.13 Published 2007 Journal Clin Neurophysiol Section Body Doc Link 17714986 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox